Summary
Elevance Health, Inc. (formerly Anthem Inc.) announced the successful closing of a significant equity offering on May 12, 2015, raising approximately $1.25 billion in gross proceeds from the sale of 25 million Equity Units. An additional option for 1.5 million units was also exercised, further increasing the total capital raised. The company intends to use these net proceeds of roughly $1.225 billion for general corporate purposes. A key planned use of these funds is to repurchase approximately $700.5 million of its outstanding 2.750% Senior Convertible Debentures due 2042. Each Equity Unit is structured as a purchase contract for a future stock purchase, combined with an undivided beneficial ownership interest in 1.90% Remarketable Subordinated Notes due 2028. The company will pay quarterly contract adjustment payments on these units. This transaction diversifies the company's capital structure and provides flexibility for debt management, specifically addressing a portion of its convertible debt. Investors should note the specifics of the Equity Unit structure, including the future obligation to purchase common stock and the interest-bearing notes involved.
Key Highlights
- 1Elevance Health (then Anthem Inc.) closed an offering of 25 million Equity Units for $1.25 billion on May 12, 2015.
- 2An additional 1.5 million Equity Units were purchased under an underwriters' option, raising further capital.
- 3Net proceeds from the offering are estimated at approximately $1.225 billion.
- 4Proceeds will be used for general corporate purposes, including the repurchase of approximately $700.5 million of its 2.750% Senior Convertible Debentures due 2042.
- 5Each Equity Unit consists of a forward purchase contract for Elevance Health's common stock and an interest in 1.90% Remarketable Subordinated Notes due 2028.
- 6Holders of Equity Units will receive quarterly contract adjustment payments at an annual rate of 3.35%.
- 7The Notes are pledged as collateral to secure the obligation to purchase shares of Common Stock under the purchase contracts.